Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 169-180 of 424
Drug study icon
RecruitingNCT06502964

ALTO-101 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 21 Years to 55 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Schizophrenia
Other study type icon
RecruitingNCT07139171

Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Tianjin
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
China
Sponsor
Tianjin Anding Hospital
Condition
Schizophrenia
Drug study icon
RecruitingNCT07467993

Safety, Tolerability, and Treatment Response of GXV813 for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States and in Bulgaria.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria
Sponsor
Novartis Pharmaceuticals
Condition
Schizophrenia
Drug study icon
RecruitingNCT07565428

Roluperidone for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Bellflower
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
Drug study icon
RecruitingNCT07363577

LB-102 for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
LB Pharmaceuticals Inc.
Condition
Schizophrenia
Other study type icon
RecruitingNCT06431009

The Danish Region Midt Schizophrenia Cohort

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Aarhus
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalOver 15 Years
Countries
Denmark
Sponsor
University of Aarhus
Condition
Schizophrenia
Drug study icon
RecruitingNCT05958875

Effect of a Six Week Intensified Pharmacological Treatment for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United Kingdom, in Austria, in Germany, ...

Multiple locations, including Innsbruck
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United Kingdom, Austria, Germany, ...
Sponsor
Dr. Inge Winter
Condition
Schizophrenia
Drug study icon
RecruitingISRCTN33465792

The effect of serotonin receptor 4 on cognition in unusual experiences

This study is looking at whether Intervention arm: Prucalopride (tablets, over-encapsulated in a vegetarian shell and filled with Lactose Monohydrate Ph can help people with community population with psychotic-like experiences in the last 12 months or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United Kingdom
Sponsor
University of Birmingham
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.